PSA 2.6 – 4.0 ng/ml

Gleason Score

Path Stage

Clinical Stage

T1c

T2a

T2b

T2c

2-4

OC

92

82-98

85

69-96

80

61-95

78

58-94

CP

8

2-18

15

4-31

20

5-39

22

6-42

SV+

0

0-0

0

0-0

0

0-0

0

0-0

LN+

0

0-0

0

0-0

0

0-0

0

0-0

5-6

OC

84

81-86

71

66-75

63

57-59

61

50-70

CP

15

13-18

27

23-31

34

28-40

36

27-45

SV+

1

0-1

2

1-3

2

1-4

2

1-5

LN+

0

0-0

0

0-1

1

0-2

1

0-4

3+4=7

OC

68

62-74

50

43-57

41

33-48

38

27-50

CP

27

22-33

41

35-48

47

40-55

48

37-59

SV+

4

2-7

7

3-12

9

4-15

8

2-17

LN+

1

0-2

2

0-4

3

0-8

5

0-15

4+3=7

OC

58

48-67

39

30-48

30

22-39

27

18-40

CP

37

29-46

52

43-61

57

47-67

57

44-70

SV+

4

1-7

6

2-12

7

3-14

6

2-16

LN+

1

0-3

2

0-6

4

0-12

7

0-21

8-10

OC

52

41-63

33

24-44

25

17-34

23

14-34

CP

40

31-50

53

44-63

57

46-68

57

44-70

SV+

6

3-12

10

4-18

12

5-22

10

3-22

LN+

1

0-4

3

0-8

5

0-14

8

0-22